Immunovant
IMVT
#3710
Rank
A$4.09 B
Marketcap
$24.12
Share price
-7.60%
Change (1 day)
-48.63%
Change (1 year)

Earnings for Immunovant (IMVT)

Earnings in 2024 (TTM): -A$0.62 Billion

According to Immunovant's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunovant from 2019 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.68 Billion59.79%
2023 -A$0.42 Billion32.6%
2022 -A$0.32 Billion39.55%
2021 -A$0.23 Billion37.3%
2020 -A$0.17 Billion780.74%
2019 -A$18.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-64.74%๐Ÿ‡บ๐Ÿ‡ธ USA